Bladder cancer: 2017 and beyond

Por Kamat, Ashish M.
Publicado no Indian J Urol (2017)

Myths and Mysteries Surrounding Bacillus Calmette-Guérin Therapy for Bladder Cancer

Por Kamat, Ashish M., Orten, Sima
Publicado no Eur Urol (2013)

Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer

Por Agarwal, Piyus K., Kamat, Ashish M.
Publicado em 2008

Optimal timing of chemotherapy and cystectomy

Por Karam, Jose A, Kamat, Ashish M
Publicado em 2010

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination

Por Jinesh G., Goodwin, Kamat, Ashish M.
Publicado em 2012

What is new in non-muscle-invasive bladder cancer in 2016?

Por Kamat, Ashish M., Bağcıoğlu, Murat, Huri, Emre
Publicado no Turk J Urol (2017)

Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL

Por Jinesh G., Goodwin, Chunduru, Srinivas, Kamat, Ashish M.
Publicado em 2012

Genetic Variations in Regulator of G-Protein Signaling (RGS) Confer Risk of Bladder Cancer

Por Lee, Eugene K., Ye, Yuanquing, Kamat, Ashish M., Wu, Xifeng
Publicado em 2013

In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy

Por Taoka, Rikiya, Williams, Stephen B., Ho, Philip L., Kamat, Ashish M.
Publicado no Can Urol Assoc J (2015)

Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo()

Por Jinesh, Goodwin G., Lee, Eugene Kang, Tran, Jonathan, Kamat, Ashish M.
Publicado no Urol Oncol (2012)

Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients

Por Li, Roger, Amrhein, John, Cohen, Zvi, Champagne, Monique, Kamat, Ashish M.
Publicado no Bladder Cancer (2017)

Curcumin Potentiates the Antitumor Effects of Gemcitabine in an Orthotopic Model of Human Bladder Cancer through Suppression of Proliferative and Angiogenic Biomarkers

Por Tharakan, Sheeja T., Inamoto, Teruo, Sung, Bokyung, Aggarwal, Bharat B., Kamat, Ashish M.
Publicado em 2009

Retraction notice to “Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic b...

Por Tharakan, Sheeja T., Inamoto, Teruo, Sung, Bokyung, Aggarwal, Bharat B., Kamat, Ashish M.
Publicado no Biochem Pharmacol (2016)

Novel PKC-ζ to p47(phox) interaction is necessary for transformation from blebbishields

Por Jinesh, Goodwin G., Taoka, Rikiya, Zhang, Qiang, Gorantla, Siddharth, Kamat, Ashish M.
Publicado no Sci Rep (2016)

Practical Use of Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: Summary of Session at the Society of Urologic Oncology Annual Meeting

Por Apolo, Andrea B., Grossman, H. Barton, Bajorin, Dean, Steinberg, Gary, Kamat, Ashish M.
Publicado em 2012

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

Por TAKEUCHI, HISASHI, MMEJE, CHINEDU O., JINESH, GOODWIN G., TAOKA, RIKIYA, KAMAT, ASHISH M.
Publicado no Oncol Rep (2015)

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis

Por Kamat, Ashish M., Cookson, Michael, Witjes, J. Alfred, Stenzl, Arnulf, Grossman, H. Barton
Publicado no Bl Cancer (2016)

1,1-Bis(3′-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth

Por Inamoto, Teruo, Papineni, Sabitha, Chintharlapalli, Sudhakar, Cho, Sung-Dae, Safe, Stephen, Kamat, Ashish M.
Publicado no Mol Cancer Ther (2008)

New discoveries in the molecular landscape of bladder cancer

Por Li, Roger, Choi, Woonyoung, Ferguson 3rd, J.E., Metcalfe, Michael J., Kamat, Ashish M.
Publicado no F1000Res (2016)

Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk

Por Wei, Hua, Kamat, Ashish M., Aldousari, Saad, Ye, Yuanqing, Huang, Maosheng, Dinney, Colin P., Wu, Xifeng
Publicado em 2012